ArticleRheumatology (Oxford, England)2022
Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study.
Fengchen OuyangPubMed ↗Publisher ↗
No numbers read from the abstract.